KREBS BIOCHEMICALS & INDUSTRIES Share Price

KREBS BIOCHEMICALS & INDUSTRIES Share Price

NSE: KREBSBIO
|
Pharmaceuticals
₹ 53.22
+₹0.62 (1.18%)
1D
Last updated 24 Jul, 2026, 15:29 IST

KREBS BIOCHEMICALS & INDUSTRIES Share Price Today

As of 25 Jul 2026, KREBS BIOCHEMICALS & INDUSTRIES share price is ₹53.22. The stock opened at ₹52.99, compared to its previous close of ₹52.60. During today's trading session, KREBS BIOCHEMICALS & INDUSTRIES share price moved in the range of ₹50.81 to ₹53.22, with an average price of ₹52.02 for the day. Looking at its last 52-week, the stock has touched a low of ₹38.33 and a high of ₹82.49. On the performance front, KREBS BIOCHEMICALS & INDUSTRIES share price has declined by 17.22% over the last six months and is down 35.12% on a year-on-year basis.

₹50.81
1.18% up today
₹53.22
1D LOW
1D HIGH

KREBS BIOCHEMICALS & INDUSTRIES Returns Calculator

Circuit
L
H
₹47.34
₹57.86
52-week
L
H
₹38.33
₹82.49
Mkt Cap Cr
114.27
P/E
-6.75
P/B
0.00
ROE
10.40%
D/E
-1.38
ROCE
-9.06%
Div. Yield
0.00%
EPS(TTM)
-7.85
Turnover
0.47
EV/EBITDA
-99.13
Net Margin
0.00%
Op. Margin
0.00%
ROA
-10.37%
Quick Ratio
0.00
Curr. Ratio
0.19
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Krebs Biochem has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Krebs Biochem appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,68,842.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

KREBS BIOCHEMICALS & INDUSTRIES Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹43.31₹50.42₹52.13₹59.70
Other Income₹0.71₹0.45₹0.62₹1.16
Total Revenue₹44.02₹50.87₹52.75₹60.86
Total Expenses₹70.94₹70.60₹77.45₹105.39
Profit Before Tax-₹26.92-₹19.73-₹24.69-₹44.53
Tax₹0.02₹0.00₹0.00₹0.00
Profit After Tax-₹26.94-₹19.73-₹24.69-₹44.53
EPS - Basic-₹12.49-₹9.15-₹11.30-₹20.81
EPS - Diluted-₹12.49-₹9.15-₹11.30-₹20.81

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹26.92-₹19.73-₹24.69-₹44.53
Income before WC changes-₹14.51-₹7.84-₹14.87-₹33.12
Change in Assets₹5.98-₹2.58₹19.12-₹13.97
Change in Liabilities₹0.66₹12.79-₹28.96₹29.87
Change in WC₹6.64₹10.21-₹9.84₹15.90
Cash flow from Operations-₹7.89₹2.36-₹24.71-₹17.22
Cash flow from Investing-₹4.97-₹7.82-₹12.65-₹22.90
Cash flow from Financing₹12.86₹5.50₹37.34₹39.51
Total Cash Flow₹0.00₹0.05-₹0.01-₹0.61
Cash (Start of the year)₹0.14₹0.09₹0.10₹0.71
Cash (End of the year)₹0.14₹0.14₹0.09₹0.10

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹158.78₹160.73₹158.92₹154.31
Current Assets₹10.26₹17.44₹16.06₹35.49
Total Assets₹169.04₹178.17₹174.98₹189.81
Current Liabilities₹103.53₹61.83₹49.10₹78.06
Net Current Asset-₹93.27-₹44.39-₹33.04-₹42.57
Non-Current Liabilities₹211.75₹235.56₹225.34₹186.83
Equity Capital-₹146.24-₹119.22-₹99.46-₹75.09
Total Equity & Liabilities₹169.04₹178.17₹174.98₹189.81
* All values are in INR Crore
Qty
Bid
50
51.9
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 50
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
34.18
Neutral
ATR (14)
3.12
Neutral
STOCH(9,6)
28.63
Neutral
STOCH RSI (14)
50.76
Neutral
ADX(9)
48.39
Bearish
UO(9)
44.43
Neutral
ROC(12)
-9.59
Bearish
WillR(14)
-83.13
Bullish
Period
Simple value
Exponential vaue
5D
53.74
53.52
10D
54.01
54.33
20D
56.07
56.2
50D
60.41
58.59
100D
58
59.5

About KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES Share Price
ISIN
INE268B01013
Sector Market Cap
₹ 114.27 Cr

Krebs Biochemicals & Industries Ltd is an India-based company, which is engaged in the business of manufacture of active pharmaceutical ingredients. The Company manufactures bulk active pharmaceutical ingredients, pharmaceutical intermediates, fine chemicals, nutraceuticals utilizing two revenue streams: contract manufacturing for large pharmaceutical and multinational companies, and development of its products for sale in global markets. Its products include Androstenedione, Lovastatin, and Simvastatin. The Company’s pilot or research and development stages products are Amlodipine, Cetirizine, Orlistat, Serratiopepetidase, Telmisartan, and Phenylephrine. The Company has two manufacturing facilities one at Regadichelaka, Nellore District and another one at Kothapalli Village, Kasimkota Mandal, Visakhapatnam District, Andhra Pradesh, India.

KREBS BIOCHEMICALS & INDUSTRIES Financial Highlights

  • Revenue: KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹25.76 crore in FY26 vs ₹44.02 crore in FY25. It showed a decrease of 41.48% on a yearly basis.
  • Operating Profit: KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹16.93 crore in FY26 vs ₹26.92 crore in FY25. It showed an increase of 37.11% on a year-on-year basis.
  • Net Profit: KREBS BIOCHEMICALS & INDUSTRIES reported a net loss of ₹16.93 crore in FY26 vs ₹26.94 crore in FY25. It showed an increase of 37.16% on a yearly basis.

KREBS BIOCHEMICALS & INDUSTRIES Quarterly Result Highlights

  • KREBS BIOCHEMICALS & INDUSTRIES reported revenue of ₹8.81 crore in Mar 2026, compared with ₹7.27 crore in Dec 2025, representing an increase of 21.18% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported an operating loss of ₹2.34 crore in Mar 2026, compared with ₹3.13 crore in Dec 2025, representing an increase of 25.24% on a quarter-on-quarter (QoQ) basis.
  • KREBS BIOCHEMICALS & INDUSTRIES reported a loss of ₹2.34 crore in Mar 2026, compared with ₹3.13 crore in Dec 2025, reflecting an increase of 25.24% on a QoQ basis.
  • The earnings per share (EPS) of KREBS BIOCHEMICALS & INDUSTRIES stood at ₹12.49 during Mar 2026.
Know more
Promoters
72.74%
FII
0.50%
Other DII
0.00%
Retail and other
26.76%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
KREBS BIOCHEMICALS & INDUSTRIES Share Price
KREBS BIOCHEMICALS & INDUSTRIES
Pharmaceuticals
Add Stock
Add Another

FAQs on KREBS BIOCHEMICALS & INDUSTRIES Share Price